IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishObjective: we assessed the association between baseline eosinophil cationic protein (ECP) levels, a sensitive marker of eosinophil activation, and clinical outcome in patients undergoing bare metal stent (BMS) implantation. Methods: basal ECP levels were measured in 110 patients (69±11 years, 88 men) undergoingBMSimplantation. Major adverse cardiac events (MACEs), defined as cardiac death, non-fatal myocardial infarction, or clinically-driven target lesion revascularization, were registered at 24-month follow-up. Results: eighteen (16.4%) patients had MACEs and showed higher ECP levels compared with those without MACEs [20.1 (9.8 47.3) vs. 9.5 (5.0 27.2) g/L, p = 0.02]. At follow-up, ECP level >11 g/L was the only significant predictor of MACEs (HR 3.5, 95% CI 1.1 10.4, p = 0.03). Conclusion: basal ECP levels are associated with MACEs after BMS implantation, suggesting that an allergic-mediated inflammation against the metal could explain some adverse reactions occurring after coronary stenting.
Niccoli, G., Sgueglia, G. A., Conte, M., Cosentino, N., Minelli, S., Belloni, F., Trani, C., Sabato, V., Burzotta, F., Porto, I., Leone, A. M., Schiavino, D., Crea, F., Eosinophil cationic protein and clinical outcome after bare metal stent implantation, <<ATHEROSCLEROSIS>>, 2011; 215 (Marzo): 166-169. [doi:21183182] [http://hdl.handle.net/10807/13701]
| Autori: | |
| Titolo: | Eosinophil cationic protein and clinical outcome after bare metal stent implantation |
| Digital Object Identifier (DOI): | http://dx.doi.org/21183182 |
| Data di pubblicazione: | 2011 |
| Abstract: | Objective: we assessed the association between baseline eosinophil cationic protein (ECP) levels, a sensitive marker of eosinophil activation, and clinical outcome in patients undergoing bare metal stent (BMS) implantation. Methods: basal ECP levels were measured in 110 patients (69±11 years, 88 men) undergoingBMSimplantation. Major adverse cardiac events (MACEs), defined as cardiac death, non-fatal myocardial infarction, or clinically-driven target lesion revascularization, were registered at 24-month follow-up. Results: eighteen (16.4%) patients had MACEs and showed higher ECP levels compared with those without MACEs [20.1 (9.8 47.3) vs. 9.5 (5.0 27.2) g/L, p = 0.02]. At follow-up, ECP level >11 g/L was the only significant predictor of MACEs (HR 3.5, 95% CI 1.1 10.4, p = 0.03). Conclusion: basal ECP levels are associated with MACEs after BMS implantation, suggesting that an allergic-mediated inflammation against the metal could explain some adverse reactions occurring after coronary stenting. |
| Lingua: | Inglese |
| Rivista: | |
| Citazione: | Niccoli, G., Sgueglia, G. A., Conte, M., Cosentino, N., Minelli, S., Belloni, F., Trani, C., Sabato, V., Burzotta, F., Porto, I., Leone, A. M., Schiavino, D., Crea, F., Eosinophil cationic protein and clinical outcome after bare metal stent implantation, <<ATHEROSCLEROSIS>>, 2011; 215 (Marzo): 166-169. [doi:21183182] [http://hdl.handle.net/10807/13701] |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2021